ASEME honors Marisa Berenguer, CEO of Ideeea Therapeutics, for leading a pioneering biotechnology project
The Spanish Association of Women Entrepreneurs (ASEME) has recognized Marisa Berenguer, CEO of Ideeea Therapeutics, as Entrepreneur of the Year for the development of AGAcell®, the first cell-based platform currently under investigation aimed at providing a treatment for androgenetic alopecia. Ideeea Therapeutics is the sponsoring company and holder of the exclusive rights to AGAcell®, the […]
ASEME premia a Marisa Berenguer, CEO de Ideeea Therapeutics, por liderar un proyecto biotecnológico pionero
The Spanish Association of Women Entrepreneurs (ASEME) has recognized Marisa Berenguer, CEO of Ideeea Therapeutics, as Entrepreneur of the Year for the development of AGAcell®, the first cell-based platform currently under investigation aimed at providing a treatment for androgenetic alopecia. Ideeea Therapeutics is the sponsoring company and holder of the exclusive rights to AGAcell®, the […]
AGAcell® on «La Vanguardia»: Ideeea Therapeutics’ Bet on Androgenetic Alopecia
A therapy based on adipose tissue–derived stem cells combined with adenosine triphosphate has demonstrated its effectiveness in reversing the effects of androgenetic alopecia in an experiment conducted in mice, led by researchers from the Department of Dermatology at Hospital Clínico San Carlos in Madrid. The study, published in Stem Cell Research & Therapy, evaluated the efficacy […]
AGAcell® on «Tele 5»: Closer to ending alopecia: Spanish stem cell research could be the solution
Closer to Ending Alopecia: A Spanish Stem Cell Study Offers New Hope A study by the Department of Dermatology at the Hospital Clínico San Carlos in Madrid has become a beacon of hope for people seeking to stop or prevent hair loss, according to an article published in the journal Stem Cell Research & Therapy. The […]
AGAcell® on «20 minutos»: A Spanish stem cell study brings the end of alopecia closer.
A Spanish stem cell study brings the end of alopecia closer. A study conducted by the Department of Dermatology at Hospital Clínico San Carlos in Madrid has become a beacon of hope for people seeking to overcome or prevent alopecia, according to an article published in the journal Stem Cell Research & Therapy. The key to […]
AGAcell® on «La Razón»: A Spanish hospital uses stem cells to treat alopecia
A Spanish hospital uses stem cells to treat alopecia Dermatologists at Hospital Clínico San Carlos in Madrid are conducting research using mesenchymal stem cells to treat androgenetic alopecia, the most prevalent form of hair loss. Androgenetic alopecia, also known as common baldness, is a dynamic and progressive hair loss disorder that affects both men and […]
AGAcell® on «El Español»:In four years, we could have a stem cell therapy to end baldness.
In four years, we could have a stem cell therapy to end baldness. A stem cell‑based therapy has succeeded in regenerating the hair of mice with induced androgenetic alopecia. The breakthrough comes from a Spanish research team led by Dr. Eduardo López Bran, Head of Dermatology at Hospital Clínico San Carlos in Madrid. López Bran and his colleagues extracted stem cells from adipose (fat) tissue, cultured […]
AGAcell® on «Antena 3»:Is the end of baldness near? This Spanish stem cell treatment has worked successfully in mice
Is the end of baldness near? This Spanish stem cell treatment has worked successfully in mice The solution to baldness may be closer than ever thanks to Spanish research. The Hospital Clínico San Carlos in Madrid has tested a technique in mice that reverses alopecia. A ray of hope for people who want to end […]
AGAcell® on «RTVE»:A Spanish Study Brings the End of Alopecia Closer
A Spanish Study Brings the End of Alopecia Closer Spanish scientists have set a five-year horizon to potentially put an end to alopecia, following a study conducted at the Hospital Clínico San Carlos in Madrid and recently published in the journal Stem Cell Research & Therapy. The key to success—so far demonstrated in mice—lies in a […]
«Europapress»: Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia
Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia Ideeea Therapeutics closes a €2.3 million seed funding round to drive the development of advanced therapy medicinal products (ATMPs) with an open science approach and strong clinical impact. Read more: Europa Press